Exact Mass: 291.0341

Exact Mass Matches: 291.0341

Found 238 metabolites which its exact mass value is equals to given mass value 291.0341, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Parathion

p-Nitrophenol O-ester with O,O-diethylphosphorothioic acid

C10H14NO5PS (291.033)


Parathion is a highly toxic cholinesterase inhibitor that is used as an acaricide and as an insecticide. D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors A highly toxic cholinesterase inhibitor that is used as an acaricide and as an insecticide. [HMDB] C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals

   

Actara

Thiamethoxam

C8H10ClN5O3S (291.0193)


D010575 - Pesticides > D007306 - Insecticides > D000073943 - Neonicotinoids D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 1241; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5832; ORIGINAL_PRECURSOR_SCAN_NO 5830 CONFIDENCE standard compound; INTERNAL_ID 1241; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5856; ORIGINAL_PRECURSOR_SCAN_NO 5853 CONFIDENCE standard compound; INTERNAL_ID 1241; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5865; ORIGINAL_PRECURSOR_SCAN_NO 5862 CONFIDENCE standard compound; INTERNAL_ID 1241; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5851; ORIGINAL_PRECURSOR_SCAN_NO 5850 CONFIDENCE standard compound; INTERNAL_ID 1241; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5874; ORIGINAL_PRECURSOR_SCAN_NO 5871 CONFIDENCE standard compound; INTERNAL_ID 1241; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5871; ORIGINAL_PRECURSOR_SCAN_NO 5868 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2941 CONFIDENCE standard compound; INTERNAL_ID 2595 CONFIDENCE standard compound; INTERNAL_ID 8471

   

Brimonidine

5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine

C11H10BrN5 (291.012)


Brimonidine is only found in individuals that have used or taken this drug. It is a drug used to treat glaucoma. It acts via decreasing aqueous humor synthesis. [Wikipedia]Brimonidine is an alpha adrenergic receptor agonist (primarily alpha-2). It has a peak ocular hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and humans suggest that Brimonidine has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics > S01GA - Sympathomimetics used as decongestants C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D - Dermatologicals Brimonidine (UK 14304) is a full α2-adrenergic receptor (α2-AR) agonist.

   
   

prontosil

p-[(2,4-diaminophenyl)azo]benzenesulphonamide

C12H13N5O2S (291.079)


A diphenyldiazene compound having two amino substituents at the 2- and 4-positions and an aminosulphonyl substituent at the 4-position. It was the first antibacterial drug, (introduced 1935) and the first of the sulfonamide antibiotics. C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent

   

Crufomate

Crufomate

C12H19ClNO3P (291.0791)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent CONFIDENCE standard compound; INTERNAL_ID 237; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9553; ORIGINAL_PRECURSOR_SCAN_NO 9552 CONFIDENCE standard compound; INTERNAL_ID 237; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9578; ORIGINAL_PRECURSOR_SCAN_NO 9577 CONFIDENCE standard compound; INTERNAL_ID 237; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9598; ORIGINAL_PRECURSOR_SCAN_NO 9597 CONFIDENCE standard compound; INTERNAL_ID 237; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9618; ORIGINAL_PRECURSOR_SCAN_NO 9616 CONFIDENCE standard compound; INTERNAL_ID 237; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9590; ORIGINAL_PRECURSOR_SCAN_NO 9588 CONFIDENCE standard compound; INTERNAL_ID 237; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9626; ORIGINAL_PRECURSOR_SCAN_NO 9624

   

1-(6-Oxo-6H-dibenzo[b,d]pyran-3-yl)-1H-pyrrole-2,5-dione

1-(6-Oxo-6H-dibenzo[b,d]pyran-3-yl)-1H-pyrrole-2,5-dione

C17H9NO4 (291.0532)


   

N-(1H-Benzotriazol-1-yl)-2,4-dichlorobenzamide

N-(1H-Benzotriazol-1-yl)-2,4-dichlorobenzamide

C13H7Cl2N3O (290.9966)


   

norsertraline

Cis-(+/-)-4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Naphthalenamine

C16H15Cl2N (291.0581)


norsertraline is a metabolite of sertraline. Sertraline hydrochloride (trademark names Zoloft and Lustral) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It was introduced to the market by Pfizer in 1991. Sertraline is primarily used to treat major depression in adult outpatients as well as obsessive–compulsive, panic, and social anxiety disorders in both adults and children. In 2007, it was the most prescribed antidepressant on the U.S. retail market, with 29,652,000 prescriptions. (Wikipedia) CONFIDENCE standard compound; EAWAG_UCHEM_ID 3623

   

Hawkinsin

2-Amino-3-{[2-(carboxymethyl)-2,5-dihydroxycyclohex-3-en-1-yl]sulphanyl}propanoic acid

C11H17NO6S (291.0777)


Hawkinsin is a sulfur amino acid identified as (2-L-cystein-S-yl-1,4-dihydroxycyclohex-5-en-1-yl)acetic acid. It is a reactive byproduct of abnormal tyrosine metabolism. Normally, the breakdown of the amino acid tyrosine involves the conversion of 4-hydroxyphenylpyruvate to homogentisate by 4-hydroxyphenylpyruvate dioxygenase. Complete deficiency of this enzyme leads to an inborn error of metabolism called tyrosinemia III. In rare cases, however, the enzyme is still able to produce the reactive intermediate 1,2-epoxyphenyl acetic acid but is unable to convert this intermediate to homogentisate (PMID: 11073718). The intermediate then spontaneously reacts with glutathione to form hawkinsin. Chronically high levels of hawkinsin are associated with hawkinsinuria (characterized by the inability to break down the amino acid tyrosine). Patients with hawkinsinuria excrete hawkinsin in their urine throughout their life. The features of this condition usually appear around the time infants are weaned off breast milk and begin to use formula. The signs and symptoms may include the following: failure to gain weight and grow at the expected rate (failure to thrive), abnormally high acid levels in the blood (acidosis), and fine or sparse hair. Hawkinsin is an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Hawkinsin is an organic acid. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated hawkinsinuria. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures. Hawkinsin is a sulfur amino acid identified as (2-l-cystein-S-yl, 4-dihydroxycyclohex-5-en-1-yl)acetic acid. Patients with hawkinsinuria excrete this metabolite in their urine throughout their life, although symptoms of metabolic acidosis and tyrosinemia improve in the first year of life. Alterations in the structure and activity of 4-hydroxyphenylpyruvic acid dioxygenase are causally related to two different metabolic disorders, tyrosinemia type III and hawkinsinuria. (PMID 11073718) [HMDB]

   

Orciprenaline-3-O-sulfate

(3-hydroxy-5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}phenyl)oxidanesulfonic acid

C11H17NO6S (291.0777)


Orciprenaline-3-O-sulfate is a metabolite of orciprenaline. Orciprenaline is a bronchodilator used in the treatment of asthma. Orciprenaline is a moderately selective beta2-adrenergic receptor agonist that stimulates receptors of the smooth muscle in the lungs, uterus, and vasculature supplying skeletal muscle, with minimal or no effect on alpha-adrenergic receptors. (Wikipedia)

   

Acetamide, N-[4-[(2-pyridinylamino)sulfonyl]phenyl]-

N-{4-[(pyridin-2-yl)sulphamoyl]phenyl}ethanimidic acid

C13H13N3O3S (291.0678)


D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

   

2',3'-Dideoxycytidine-5'-monophosphate

{[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}phosphonic acid

C9H14N3O6P (291.062)


   

Cloranolol

1-(2,5-Dichlorophenoxy)-3-tertiary-butylamino-2-propanol

C13H19Cl2NO2 (291.0793)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

Lobenzarit

2-[(2-carboxyphenyl)amino]-4-chlorobenzoic acid

C14H10ClNO4 (291.0298)


   

Prontosil

4-[2-(2,4-Diaminophenyl)diazen-1-yl]benzene-1-sulphonamide

C12H13N5O2S (291.079)


   

N-[2,6-Dichloro-4-(2-chloroethyl)phenyl]-4,5-dihydro-1H-imidazol-2-amine

N-[2,6-Dichloro-4-(2-chloroethyl)phenyl]-4,5-dihydro-1H-imidazol-2-amine

C11H12Cl3N3 (291.0097)


   

Thiamethoxam

3-((2-Chloro-5-thiazolyl)methyl)tetrahydro-5-methyl-N-nitro-4H-1,3,5-oxadiazin-4-imine

C8H10ClN5O3S (291.0193)


   

Tifenazoxide

6-chloro-3-[(1-methylcyclopropyl)imino]-2H,3H,4H-1lambda6-thieno[3,2-e][1,2,4]thiadiazine-1,1-dione

C9H10ClN3O2S2 (290.9903)


   

zomepirac

5-(4-Chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetate dihydrate

C15H14ClNO3 (291.0662)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

parathion

parathion

C10H14NO5PS (291.033)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 3115 D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals

   

Oxostephanosine

Oxostephanosine

C17H9NO4 (291.0532)


   

Megistoquinone II

Megistoquinone II

C14H13NO6 (291.0743)


   

Epoxyquinomicin C

Epoxyquinomicin C

C14H13NO6 (291.0743)


   
   

Ethyl 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-1,3-thiazole-4-carboxylate

Ethyl 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-1,3-thiazole-4-carboxylate

C14H13NO4S (291.0565)


   

zomepirac

zomepirac

C15H14ClNO3 (291.0662)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   
   
   
   

5-Cytidine monophosphate

5-Cytidine monophosphate

C9H14N3O6P (291.062)


   
   

oxoanolobine

oxoanolobine

C17H9NO4 (291.0532)


   

Ndelta-Phosphosulfamylornithine

Ndelta-Phosphosulfamylornithine

C5H14N3O7PS (291.029)


   
   

6-bromo-2-(1,1-dimethyl-2-propenyl)-1h-indole-3-carbaldehyde

6-bromo-2-(1,1-dimethyl-2-propenyl)-1h-indole-3-carbaldehyde

C14H14BrNO (291.0259)


   

E-dimethyl rhoifolinate

E-dimethyl rhoifolinate

C14H13NO6 (291.0743)


   
   

Oxopukateine

Oxopukateine

C17H9NO4 (291.0532)


   

p-Chlorphenylpremercapturinsaeure

p-Chlorphenylpremercapturinsaeure

C11H14ClNO4S (291.0332)


   

norsertraline

Cis-(+/-)-4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Naphthalenamine

C16H15Cl2N (291.0581)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3623 CONFIDENCE standard compound; INTERNAL_ID 1566

   

Indatraline

Indatraline

C16H15Cl2N (291.0581)


C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Thiamethoxam

Pesticide5_Thiamethoxam_C8H10ClN5O3S_4H-1,3,5-Oxadiazin-4-imine, 3-[(2-chloro-5-thiazolyl)methyl]tetrahydro-5-methyl-N-nitro-, (4E)-

C8H10ClN5O3S (291.0193)


D010575 - Pesticides > D007306 - Insecticides > D000073943 - Neonicotinoids D016573 - Agrochemicals

   

Zomepirac; AIF; CE0; CorrDec

Zomepirac; AIF; CE0; CorrDec

C15H14ClNO3 (291.0662)


   

Zomepirac; AIF; CE10; CorrDec

Zomepirac; AIF; CE10; CorrDec

C15H14ClNO3 (291.0662)


   

Zomepirac; AIF; CE30; CorrDec

Zomepirac; AIF; CE30; CorrDec

C15H14ClNO3 (291.0662)


   

Zomepirac; AIF; CE0; MS2Dec

Zomepirac; AIF; CE0; MS2Dec

C15H14ClNO3 (291.0662)


   

Zomepirac; AIF; CE10; MS2Dec

Zomepirac; AIF; CE10; MS2Dec

C15H14ClNO3 (291.0662)


   

Zomepirac; AIF; CE30; MS2Dec

Zomepirac; AIF; CE30; MS2Dec

C15H14ClNO3 (291.0662)


   

Metaproterenol 3-O-sulfate

Metaproterenol 3-O-sulfate

C11H17NO6S (291.0777)


   

Desmethylsertraline

Desmethylsertraline

C16H15Cl2N (291.0581)


   

N4-Acetylsulfapyridine

N4-Acetylsulfapyridine

C13H13N3O3S (291.0678)


   

Zalcitabine monophosphate

Zalcitabine monophosphate

C9H14N3O6P (291.062)


   

5-BROMO-2-PHENYLAMINO-BENZOIC ACID

5-BROMO-2-PHENYLAMINO-BENZOIC ACID

C13H10BrNO2 (290.9895)


   

2-Chloro-N-(5-cyclopropyl-1H-pyrazol-3-yl)thieno[3,2-d]pyrimidin- 4-amine

2-Chloro-N-(5-cyclopropyl-1H-pyrazol-3-yl)thieno[3,2-d]pyrimidin- 4-amine

C12H10ClN5S (291.0345)


   

Ketone 2-amino-4,5,6,7-tetrahydrobenzo[b]thien-3-yl o-chlorophenyl

Ketone 2-amino-4,5,6,7-tetrahydrobenzo[b]thien-3-yl o-chlorophenyl

C15H14ClNOS (291.0485)


   

ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate

ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate

C14H13NO4S (291.0565)


   

6-BROMO-2-PIPERAZIN-1-YL-QUINOLINE

6-BROMO-2-PIPERAZIN-1-YL-QUINOLINE

C13H14BrN3 (291.0371)


   

4-(1-Pyrrolidinylsulforylmenthyl)phenylhydrazine hydrochloride

4-(1-Pyrrolidinylsulforylmenthyl)phenylhydrazine hydrochloride

C11H18ClN3O2S (291.0808)


   

n-isopropyl 3-bromo-4-methylbenzenesulfonamide

n-isopropyl 3-bromo-4-methylbenzenesulfonamide

C10H14BrNO2S (290.9929)


   

Amidapsone

Amidapsone

C13H13N3O3S (291.0678)


C254 - Anti-Infective Agent > C849 - Sulfone Anti-Infective Agent

   

2-(3,4,5-trimethoxyphenyl)-1,3-thiazolidine,hydrochloride

2-(3,4,5-trimethoxyphenyl)-1,3-thiazolidine,hydrochloride

C12H18ClNO3S (291.0696)


   

2-(2-methyl-2H-pyridin-1-yl)-1-phenyl-ethanone

2-(2-methyl-2H-pyridin-1-yl)-1-phenyl-ethanone

C14H14BrNO (291.0259)


   

[2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methanol

[2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methanol

C12H9F4NOS (291.0341)


   

5-(chloromethyl)-4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole

5-(chloromethyl)-4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole

C12H9ClF3NS (291.0096)


   

tert-butyl 4-(2-bromoethyl)piperidine-1-carboxylate

tert-butyl 4-(2-bromoethyl)piperidine-1-carboxylate

C12H22BrNO2 (291.0834)


   

4-Chloro-2-methyl-3-(3-oxobutyl)quinoline-6-carboxylic acid

4-CHLORO-2-METHYL-3-(3-OXO-BUTYL)-QUINOLINE-6-CARBOXYLIC ACID

C15H14ClNO3 (291.0662)


   

Azure A

7-Amino-N,N-dimethyl-3H-phenothiazin-3-iminium chloride

C14H14ClN3S (291.0597)


D004396 - Coloring Agents > D001399 - Azure Stains

   

1-(4-BROMOBUTOXY)-4-METHYLBENZENE

1-(4-BROMOBUTOXY)-4-METHYLBENZENE

C14H14BrNO (291.0259)


   

4-(METHYL-PHENYL-SULFAMOYL)-BENZOIC ACID

4-(METHYL-PHENYL-SULFAMOYL)-BENZOIC ACID

C14H13NO4S (291.0565)


   

4-(2-bromoacetamido)-2,2,6,6-tetramethyl-1-piperidinyloxy

4-(2-bromoacetamido)-2,2,6,6-tetramethyl-1-piperidinyloxy

C11H20BrN2O2 (291.0708)


   

3-OXO-6-(TRIFLUOROMETHYL)-3,4-DIHYDRO-2H-1,4-BENZOTHIAZIN-2-YL]ACETIC ACID

3-OXO-6-(TRIFLUOROMETHYL)-3,4-DIHYDRO-2H-1,4-BENZOTHIAZIN-2-YL]ACETIC ACID

C11H8F3NO3S (291.0177)


   

2-bromo-n-(4-hydroxyphenyl)benzamide

2-bromo-n-(4-hydroxyphenyl)benzamide

C13H10BrNO2 (290.9895)


   

2-CHLORO-5-{[ISOPROPYL(METHYL)AMINO]SULFONYL}BENZOIC ACID

2-CHLORO-5-{[ISOPROPYL(METHYL)AMINO]SULFONYL}BENZOIC ACID

C11H14ClNO4S (291.0332)


   
   

tert-butyl 3-(2-bromoacetyl)pyrrolidine-1-carboxylate

tert-butyl 3-(2-bromoacetyl)pyrrolidine-1-carboxylate

C11H18BrNO3 (291.047)


   

4-(6-bromopyridin-2-yl)-2-methylbenzoic acid

4-(6-bromopyridin-2-yl)-2-methylbenzoic acid

C13H10BrNO2 (290.9895)


   

4-BROMO-2-(N-BOC-AMINOMETHYL)THIOPHENE

4-BROMO-2-(N-BOC-AMINOMETHYL)THIOPHENE

C10H14BrNO2S (290.9929)


   

4-(4-Bromophenoxy)piperidine hydrochloride (1:1)

4-(4-Bromophenoxy)piperidine hydrochloride (1:1)

C11H15BrClNO (291.0025)


   

5-(Benzyloxy)-6-bromopicolinaldehyde

5-(Benzyloxy)-6-bromopicolinaldehyde

C13H10BrNO2 (290.9895)


   

4-bromo-N-butylbenzenesulfonamide

4-bromo-N-butylbenzenesulfonamide

C10H14BrNO2S (290.9929)


   

4-(4-Methylphenylsulfonamido)benzoic acid

4-(4-Methylphenylsulfonamido)benzoic acid

C14H13NO4S (291.0565)


   

2,3,5,6-TETRAFLUORO-4-(PHENYLSULPHONYL)PYRIDINE

2,3,5,6-TETRAFLUORO-4-(PHENYLSULPHONYL)PYRIDINE

C11H5F4NO2S (290.9977)


   

2-HYDROXY-6-METHYL-3-NITROPYRIDINE

2-HYDROXY-6-METHYL-3-NITROPYRIDINE

C12H15Cl2NO3 (291.0429)


   
   

3,3,4,4,5,5,6,6,6-NONAFLUORO-1-NITRO-1-HEXENE

3,3,4,4,5,5,6,6,6-NONAFLUORO-1-NITRO-1-HEXENE

C6H2F9NO2 (290.9942)


   

3-(2,5,5-Trimethyl-1,3-dioxan-2-yl)thiophene-2-sulfonamide

3-(2,5,5-Trimethyl-1,3-dioxan-2-yl)thiophene-2-sulfonamide

C11H17NO4S2 (291.0599)


   

3-[(4-Amino-3-methylphenyl)azo]benzenesulfonic acid

3-[(4-Amino-3-methylphenyl)azo]benzenesulfonic acid

C13H13N3O3S (291.0678)


   

2,4,6-trichloro-N-(cyclohexylmethyl)aniline

2,4,6-trichloro-N-(cyclohexylmethyl)aniline

C13H16Cl3N (291.0348)


   

n-acetyl-n-acetoxy-4-chlorobenzenesulfonamide

n-acetyl-n-acetoxy-4-chlorobenzenesulfonamide

C10H10ClNO5S (290.9968)


   

3-CHLORO-4-METHOXY-3-NITROBENZOPHENONE

3-CHLORO-4-METHOXY-3-NITROBENZOPHENONE

C14H10ClNO4 (291.0298)


   

4-(3-bromophenoxy)piperidine,hydrochloride

4-(3-bromophenoxy)piperidine,hydrochloride

C11H15BrClNO (291.0025)


   

2-bromo-1-[6-(dimethylamino)naphthalen-2-yl]ethanone

2-bromo-1-[6-(dimethylamino)naphthalen-2-yl]ethanone

C14H14BrNO (291.0259)


   

2-(2-ETHOXYETHOXY)ANILINE

2-(2-ETHOXYETHOXY)ANILINE

C11H15Cl2N3O2 (291.0541)


   

8-Bromo-2-(piperazin-1-yl)quinoline

8-Bromo-2-(piperazin-1-yl)quinoline

C13H14BrN3 (291.0371)


   

1-(4-Bromophenyl)-N-propylmethanesulfonamide

1-(4-Bromophenyl)-N-propylmethanesulfonamide

C10H14BrNO2S (290.9929)


   

N-(3,4-dichlorophenyl)-N-methyl-1H-benzimidazol-2-amine

N-(3,4-dichlorophenyl)-N-methyl-1H-benzimidazol-2-amine

C14H11Cl2N3 (291.033)


   

1,3-Dithietane-2-carboxylic acid, 4-[1-(aminocarbonyl)-2-(1,1-dimethylethoxy)-2-oxoethylidene]

1,3-Dithietane-2-carboxylic acid, 4-[1-(aminocarbonyl)-2-(1,1-dimethylethoxy)-2-oxoethylidene]

C10H13NO5S2 (291.0235)


   

5-(BENZYLOXY)-2-BROMO-4-METHYLANILINE

5-(BENZYLOXY)-2-BROMO-4-METHYLANILINE

C14H14BrNO (291.0259)


   

Lobenzarit

Lobenzarit

C14H10ClNO4 (291.0298)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C26170 - Protective Agent > C275 - Antioxidant D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

2-(5-(MORPHOLINOSULFONYL)THIOPHEN-2-YL)ACETIC ACID

2-(5-(MORPHOLINOSULFONYL)THIOPHEN-2-YL)ACETIC ACID

C10H13NO5S2 (291.0235)


   

4-bromo-n-isopropylamphetamine hydrochloride

4-bromo-n-isopropylamphetamine hydrochloride

C12H19BrClN (291.0389)


   

3-(Piperazin-1-yl)benzo[d]isothiazole dihydrochloride

3-(Piperazin-1-yl)benzo[d]isothiazole dihydrochloride

C11H15Cl2N3S (291.0364)


   

2-(5-CHLOROCARBONYL-2-OXAZOLYL)-5,6-METHYLENEDIOXYBENZOFURAN (OMB-COCL)

2-(5-CHLOROCARBONYL-2-OXAZOLYL)-5,6-METHYLENEDIOXYBENZOFURAN (OMB-COCL)

C13H6ClNO5 (290.9934)


   

1-(4-Bromophenyl)-N-isopropylmethanesulfonamide

1-(4-Bromophenyl)-N-isopropylmethanesulfonamide

C10H14BrNO2S (290.9929)


   

N-[4-(pyridin-3-ylsulfamoyl)phenyl]acetamide

N-[4-(pyridin-3-ylsulfamoyl)phenyl]acetamide

C13H13N3O3S (291.0678)


   

4-BROMO-1-(PIPERAZIN-1-YL)ISOQUINOLINE

4-BROMO-1-(PIPERAZIN-1-YL)ISOQUINOLINE

C13H14BrN3 (291.0371)


   

2-Bromo-N-(2-methyl-2-propanyl)benzenesulfonamide

2-Bromo-N-(2-methyl-2-propanyl)benzenesulfonamide

C10H14BrNO2S (290.9929)


   

2-Bromo-N,N-diethylbenzenesulfonamide

2-Bromo-N,N-diethylbenzenesulfonamide

C10H14BrNO2S (290.9929)


   

5-bromo-2-(pyridin-3-ylmethoxy)benzaldehyde

5-bromo-2-(pyridin-3-ylmethoxy)benzaldehyde

C13H10BrNO2 (290.9895)


   

(S)-(+)-NBD-PY-NCS

(S)-(+)-NBD-PY-NCS

C11H9N5O3S (291.0426)


   

methyl 3-(6-bromopyridin-2-yl)benzoate

methyl 3-(6-bromopyridin-2-yl)benzoate

C13H10BrNO2 (290.9895)


   

1H-Benz[g]indole-3-carboxaldehyde,2-(5-methyl-2-thienyl)-(9CI)

1H-Benz[g]indole-3-carboxaldehyde,2-(5-methyl-2-thienyl)-(9CI)

C18H13NOS (291.0718)


   

2-(4-[(3,4-DICHLOROBENZYL)OXY]PHENYL)ACETONITRILE

2-(4-[(3,4-DICHLOROBENZYL)OXY]PHENYL)ACETONITRILE

C15H11Cl2NO (291.0218)


   

ethyl 5-(methoxycarbonylsulfamoyl)-1-methylpyrazole-4-carboxylate

ethyl 5-(methoxycarbonylsulfamoyl)-1-methylpyrazole-4-carboxylate

C9H13N3O6S (291.0525)


   

N-t-Butyl 4-bromobenzenesulfonamide

N-t-Butyl 4-bromobenzenesulfonamide

C10H14BrNO2S (290.9929)


   

3-(2-Bromoacetamidomethyl)-PROXYL3-(2-Bromoacetamidomethyl)-2,2,5,5-tetramethyl-1-pyrrolidinoxy

3-(2-Bromoacetamidomethyl)-PROXYL3-(2-Bromoacetamidomethyl)-2,2,5,5-tetramethyl-1-pyrrolidinoxy

C11H20BrN2O2 (291.0708)


   

3-Bromo-N-(tert-butyl)benzenesulfonamide

3-Bromo-N-(tert-butyl)benzenesulfonamide

C10H14BrNO2S (290.9929)


   

6-BROMO-2,2-DIMETHYLCHROMAN-4-AMINE

6-BROMO-2,2-DIMETHYLCHROMAN-4-AMINE

C11H15BrClNO (291.0025)


   

Radafaxine hydrochloride

Radafaxine (hydrochloride)

C13H19Cl2NO2 (291.0793)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Tert-butyl [4-(chlorosulfonyl)phenyl]carbamate

Tert-butyl [4-(chlorosulfonyl)phenyl]carbamate

C11H14ClNO4S (291.0332)


   

4-chloro-6-nitro-7-propan-2-yloxyquinoline-3-carbonitrile

4-chloro-6-nitro-7-propan-2-yloxyquinoline-3-carbonitrile

C13H10ClN3O3 (291.0411)


   

1-(benzenesulfonyl)-6-chloroindole

1-(benzenesulfonyl)-6-chloroindole

C14H10ClNO2S (291.0121)


   

5-bromo-N-(pyridin-3-ylmethyl)pyridine-3-carboxamide

5-bromo-N-(pyridin-3-ylmethyl)pyridine-3-carboxamide

C12H10BrN3O (291.0007)


   

2-(3-Bromo-phenylamino)-benzoic acid

2-(3-Bromo-phenylamino)-benzoic acid

C13H10BrNO2 (290.9895)


   

Benzyl (2,4-difluoro-3-formylphenyl)carbamate

Benzyl (2,4-difluoro-3-formylphenyl)carbamate

C15H11F2NO3 (291.0707)


   

[3-(Benzylsulfamoyl)phenyl]boronic acid

[3-(Benzylsulfamoyl)phenyl]boronic acid

C13H14BNO4S (291.0737)


   

2-Chloro-N-[4-(1H-indol-3-yl)-1,3-thiazol-2-yl]acetamide

2-Chloro-N-[4-(1H-indol-3-yl)-1,3-thiazol-2-yl]acetamide

C13H10ClN3OS (291.0233)


   

4-(6-bromopyridin-2-yl)-3-methylbenzoic acid

4-(6-bromopyridin-2-yl)-3-methylbenzoic acid

C13H10BrNO2 (290.9895)


   

N-[2-(Piperazin-1-yl)phenyl]methylsulphonamide hydrochloride

N-[2-(Piperazin-1-yl)phenyl]methylsulphonamide hydrochloride

C11H18ClN3O2S (291.0808)


   

6-BROMO-2-CYCLOPROPYLQUINOLINE-4-CARBOXYLICACID

6-BROMO-2-CYCLOPROPYLQUINOLINE-4-CARBOXYLICACID

C13H10BrNO2 (290.9895)


   

3,3,3-trifluoro-2-methyl-2-(phenylmethoxycarbonylamino)propanoic acid

3,3,3-trifluoro-2-methyl-2-(phenylmethoxycarbonylamino)propanoic acid

C12H12F3NO4 (291.0718)


   

1-(4-bromo-3-methylphenyl)-2,5-dimethylpyrrole-3-carbaldehyde

1-(4-bromo-3-methylphenyl)-2,5-dimethylpyrrole-3-carbaldehyde

C14H14BrNO (291.0259)


   

CHEMBRDG-BB 6619297

CHEMBRDG-BB 6619297

C14H10ClNO4 (291.0298)


   

tert-butyl 3-(2-bromoethyl)piperidine-1-carboxylate

tert-butyl 3-(2-bromoethyl)piperidine-1-carboxylate

C12H22BrNO2 (291.0834)


   

3-[(4-methylphenyl)sulfonylamino]benzoate

3-[(4-methylphenyl)sulfonylamino]benzoate

C14H13NO4S (291.0565)


   

Phenyl 2-amino-5-bromobenzoate

Phenyl 2-amino-5-bromobenzoate

C13H10BrNO2 (290.9895)


   

1H-Indazol-5-amine, 1-[(3,4-dichlorophenyl)methyl]

1H-Indazol-5-amine, 1-[(3,4-dichlorophenyl)methyl]

C14H11Cl2N3 (291.033)


   

METHYL 7-NITRO-5-OXO-3,5-DIHYDRO-2H-OXAZOLO[2,3-B]QUINAZOLINE-8-CARBOXYLATE

METHYL 7-NITRO-5-OXO-3,5-DIHYDRO-2H-OXAZOLO[2,3-B]QUINAZOLINE-8-CARBOXYLATE

C12H9N3O6 (291.0491)


   

ethyl (E)-3-(2-chlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate

ethyl (E)-3-(2-chlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate

C14H14ClN3O2 (291.0774)


   

2,3-PYRIDINEDICARBOXYLIC ACID, 5-(TRIFLUOROMETHYL)-, DIETHYL ESTER

2,3-PYRIDINEDICARBOXYLIC ACID, 5-(TRIFLUOROMETHYL)-, DIETHYL ESTER

C12H12F3NO4 (291.0718)


   

2-[(4-methylphenyl)sulfonylamino]benzoic acid

2-[(4-methylphenyl)sulfonylamino]benzoic acid

C14H13NO4S (291.0565)


   

2-{[METHYL(PHENYL)AMINO]SULFONYL}BENZOIC ACID

2-{[METHYL(PHENYL)AMINO]SULFONYL}BENZOIC ACID

C14H13NO4S (291.0565)


   

4-Chloro-3-diethylsulfaMoyl-benzoic acid

4-Chloro-3-diethylsulfaMoyl-benzoic acid

C11H14ClNO4S (291.0332)


   

3-[(TERT-BUTYLAMINO)SULFONYL]-4-CHLOROBENZOIC ACID

3-[(TERT-BUTYLAMINO)SULFONYL]-4-CHLOROBENZOIC ACID

C11H14ClNO4S (291.0332)


   

1-(2,6-dichlorophenyl)indole-2,3-dione

1-(2,6-dichlorophenyl)indole-2,3-dione

C14H7Cl2NO2 (290.9854)


   

2-(2,5-DIMETHOXYPHENYLTHIO)PYRIDINE-3-CARBOXYLIC ACID

2-(2,5-DIMETHOXYPHENYLTHIO)PYRIDINE-3-CARBOXYLIC ACID

C14H13NO4S (291.0565)


   

tert-Butyl N-[(5-bromo-2-thienyl)methyl]carbamate

tert-Butyl N-[(5-bromo-2-thienyl)methyl]carbamate

C10H14BrNO2S (290.9929)


   

tert-butyl N-[(2-bromothiophen-3-yl)methyl]carbamate

tert-butyl N-[(2-bromothiophen-3-yl)methyl]carbamate

C10H14BrNO2S (290.9929)


   

(R)-(-)-NBD-PY-NCS

(R)-(-)-NBD-PY-NCS

C11H9N5O3S (291.0426)


   
   

7-BENZYL-3-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE

7-BENZYL-3-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE

C13H14BrN3 (291.0371)


   

7-Amino-3-(1-pyridylmethyl)-3-cephem-4-carboxylic Acid

7-Amino-3-(1-pyridylmethyl)-3-cephem-4-carboxylic Acid

C13H13N3O3S (291.0678)


   

S)-2-((Methoxycarbonyl)amino)-3-Methylbutanoic acid

S)-2-((Methoxycarbonyl)amino)-3-Methylbutanoic acid

C13H14BrN3 (291.0371)


   

Rubber Accelerator SDBC

Rubber Accelerator SDBC

C9H18NS4Na (291.022)


   

2-chloro-N-(2,5-dimethoxyphenyl)benzamide

2-chloro-N-(2,5-dimethoxyphenyl)benzamide

C15H14ClNO3 (291.0662)


   

2,6-Dichloro-4-nitro-benzoic acid tert-butyl ester

2,6-Dichloro-4-nitro-benzoic acid tert-butyl ester

C11H11Cl2NO4 (291.0065)


   

(S,S)-Hydroxy Bupropion

(S,S)-Hydroxy Bupropion

C13H19Cl2NO2 (291.0793)


   

(5-((((Benzyloxy)carbonyl)amino)methyl)thiophen-2-yl)boronic acid

(5-((((Benzyloxy)carbonyl)amino)methyl)thiophen-2-yl)boronic acid

C13H14BNO4S (291.0737)


   

1-(5-Bromo-6-methylpyridin-2-yl)piperazine hydrochloride

1-(5-Bromo-6-methylpyridin-2-yl)piperazine hydrochloride

C10H15BrClN3 (291.0138)


   

3-Bromo-5-methyl-N-propylbenzenesulfonamide

3-Bromo-5-methyl-N-propylbenzenesulfonamide

C10H14BrNO2S (290.9929)


   

2-Bromo-N-butylbenzenesulfonamide

2-Bromo-N-butylbenzenesulfonamide

C10H14BrNO2S (290.9929)


   

Benzamide,N-(4-bromophenyl)-2-hydroxy-

Benzamide,N-(4-bromophenyl)-2-hydroxy-

C13H10BrNO2 (290.9895)


   

3-Bromo-N,N-diethylbenzenesulfonamide

3-Bromo-N,N-diethylbenzenesulfonamide

C10H14BrNO2S (290.9929)


   

ethyl 2-(2,3-dihydro-1,4-benzodioxin-3-yl)-1,3-thiazole-4-carboxylate

ethyl 2-(2,3-dihydro-1,4-benzodioxin-3-yl)-1,3-thiazole-4-carboxylate

C14H13NO4S (291.0565)


   

4-Bromo-N-isopropyl-3-methylbenzenesulfonamide

4-Bromo-N-isopropyl-3-methylbenzenesulfonamide

C10H14BrNO2S (290.9929)


   

1,3-Diphenylguanidine hydrobromide (1:1)

1,3-Diphenylguanidine hydrobromide (1:1)

C13H14BrN3 (291.0371)


   

7-BENZYL-1-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE

7-BENZYL-1-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE

C13H14BrN3 (291.0371)


   

4-(5-iodopyrimidin-4-yl)morpholine

4-(5-iodopyrimidin-4-yl)morpholine

C8H10IN3O (290.9869)


   

N-(4-acetylphenyl)-4-hydroxybenzenesulfonamide

N-(4-acetylphenyl)-4-hydroxybenzenesulfonamide

C14H13NO4S (291.0565)


   

5-(3,5-dichlorophenyl)-3-pyridin-2-yl-1,2,4-oxadiazole

5-(3,5-dichlorophenyl)-3-pyridin-2-yl-1,2,4-oxadiazole

C13H7Cl2N3O (290.9966)


   

4-Bromo-N,N-diethylbenzenesulfonamide

4-Bromo-N,N-diethylbenzenesulfonamide

C10H14BrNO2S (290.9929)


   

3-bromo-N-butylbenzenesulfonamide

3-bromo-N-butylbenzenesulfonamide

C10H14BrNO2S (290.9929)


   

[4-(Benzylsulfamoyl)phenyl]boronic acid

[4-(Benzylsulfamoyl)phenyl]boronic acid

C13H14BNO4S (291.0737)


   

6-BROMO-4-(PIPERAZIN-1-YL)QUINOLINE

6-BROMO-4-(PIPERAZIN-1-YL)QUINOLINE

C13H14BrN3 (291.0371)


   

3-Bromo-7-(furan-2-yl)-2,5-dimethylpyrazolo[1,5-a]pyrimidine

3-Bromo-7-(furan-2-yl)-2,5-dimethylpyrazolo[1,5-a]pyrimidine

C12H10BrN3O (291.0007)


   

(2S)-ETHYL 2-((CHLORO(PHENOXY)PHOSPHORYL)AMINO)PROPANOATE

(2S)-ETHYL 2-((CHLORO(PHENOXY)PHOSPHORYL)AMINO)PROPANOATE

C11H15ClNO4P (291.0427)


   

Dasotraline

Dasotraline

C16H15Cl2N (291.0581)


C78272 - Agent Affecting Nervous System

   

(2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)(4-chlorophenyl)methanone

(2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)(4-chlorophenyl)methanone

C15H14ClNOS (291.0485)


   

Cytidine 5-monophosphate

2,3-Dideoxycytidine-5-monophosphate

C9H14N3O6P (291.062)


   

5-Methyl-2-[(phenylsulfonyl)amino]benzoic acid

5-Methyl-2-[(phenylsulfonyl)amino]benzoic acid

C14H13NO4S (291.0565)


   

Tifenazoxide

Tifenazoxide

C9H10ClN3O2S2 (290.9903)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent

   

6-(3-Bromophenyl)-2-methylnicotinic acid

6-(3-Bromophenyl)-2-methylnicotinic acid

C13H10BrNO2 (290.9895)


   

4-(4-Chlorophenyl)-2-(2-cyclopentylidenehydrazinyl)thiazole

4-(4-Chlorophenyl)-2-(2-cyclopentylidenehydrazinyl)thiazole

C14H14ClN3S (291.0597)


   
   

Alizarine Blue

Alizarine Blue

C17H9NO4 (291.0532)


   

N-(4-methylphenyl)sulfonylbenzenecarbothioamide

N-(4-methylphenyl)sulfonylbenzenecarbothioamide

C14H13NO2S2 (291.0388)


   

5-[2-(4-Fluoroanilino)vinyl]-3-(methylsulfanyl)-4-isothiazolecarbonitrile

5-[2-(4-Fluoroanilino)vinyl]-3-(methylsulfanyl)-4-isothiazolecarbonitrile

C13H10FN3S2 (291.03)


   

3-[[(4-Methoxyphenyl)-oxomethyl]amino]-2-thiophenecarboxylic acid methyl ester

3-[[(4-Methoxyphenyl)-oxomethyl]amino]-2-thiophenecarboxylic acid methyl ester

C14H13NO4S (291.0565)


   

2-[[2-furanyl(oxo)methyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylic acid methyl ester

2-[[2-furanyl(oxo)methyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylic acid methyl ester

C14H13NO4S (291.0565)


   

6-(4-Bromophenyl)-2-methylpyridine-3-carboxylic acid

6-(4-Bromophenyl)-2-methylpyridine-3-carboxylic acid

C13H10BrNO2 (290.9895)


   

N-acetyldichloro-L-tyrosine

N-acetyldichloro-L-tyrosine

C11H11Cl2NO4 (291.0065)


   

alpha-Methyldopa-3-0-sulfate

alpha-Methyldopa-3-0-sulfate

C10H13NO7S (291.0413)


   

(5r)-2-Sulfanyl-5-[4-(Trifluoromethyl)benzyl]-1,3-Thiazol-4-One

(5r)-2-Sulfanyl-5-[4-(Trifluoromethyl)benzyl]-1,3-Thiazol-4-One

C11H8F3NOS2 (290.9999)


   

Cloranolol

Cloranolol

C13H19Cl2NO2 (291.0793)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

(2-l-cystein-S-yl-1,4-dihydroxycyclohex-5-en-1-yl)-acetic acid

(2-l-cystein-S-yl-1,4-dihydroxycyclohex-5-en-1-yl)-acetic acid

C11H17NO6S (291.0777)


   

13-Hydroxynorjavanicin

13-Hydroxynorjavanicin

C14H11O7- (291.0505)


   

2-methyl-N-(2,3,4,5,6-pentafluorophenyl)-3-furancarboxamide

2-methyl-N-(2,3,4,5,6-pentafluorophenyl)-3-furancarboxamide

C12H6F5NO2 (291.0319)


   

4-(4-Chlorophenyl)-1-methyl-2-(methylthio)-6-oxo-5-pyrimidinecarbonitrile

4-(4-Chlorophenyl)-1-methyl-2-(methylthio)-6-oxo-5-pyrimidinecarbonitrile

C13H10ClN3OS (291.0233)


   

2-{[3-(2-Furyl)acryloyl]amino}-4,5-dimethyl-3-thiophenecarboxylic acid

2-{[3-(2-Furyl)acryloyl]amino}-4,5-dimethyl-3-thiophenecarboxylic acid

C14H13NO4S (291.0565)


   
   

N-(5-chloro-2-hydroxyphenyl)-2-ethoxybenzamide

N-(5-chloro-2-hydroxyphenyl)-2-ethoxybenzamide

C15H14ClNO3 (291.0662)


   

N-(5-chloro-2-hydroxyphenyl)-2-(4-methoxyphenyl)acetamide

N-(5-chloro-2-hydroxyphenyl)-2-(4-methoxyphenyl)acetamide

C15H14ClNO3 (291.0662)


   

(3,5-Dichloro-2,4,6-trihydroxyphenyl)hexan-1-one(1-)

(3,5-Dichloro-2,4,6-trihydroxyphenyl)hexan-1-one(1-)

C12H13Cl2O4- (291.0191)


A phenolate anion resulting from removal of the proton from the phenolic hydroxy group of (3,5-dichloro-2,4,6-trihydroxyphenyl)hexan-1-one that is para to the hexanoyl group. The major structure at pH 7.3.

   

5-nitro-2-[[5-(triluoromethyl)-1H-1,2,4-triazol-3-yl]sulanyl]pyridine

5-nitro-2-[[5-(triluoromethyl)-1H-1,2,4-triazol-3-yl]sulanyl]pyridine

C8H4F3N5O2S (291.0038)


   

4-Hydroxy-3,6-dioxo-2,5-diphenylcyclohexa-1,4-dien-1-olate

4-Hydroxy-3,6-dioxo-2,5-diphenylcyclohexa-1,4-dien-1-olate

C18H11O4- (291.0657)


   

(2R)-2-amino-N-[4-chloro-2-[oxo(1H-pyrrol-2-yl)methyl]phenyl]propanamide

(2R)-2-amino-N-[4-chloro-2-[oxo(1H-pyrrol-2-yl)methyl]phenyl]propanamide

C14H14ClN3O2 (291.0774)


   

3-amino-N-[4-chloro-2-[oxo(1H-pyrrol-2-yl)methyl]phenyl]propanamide

3-amino-N-[4-chloro-2-[oxo(1H-pyrrol-2-yl)methyl]phenyl]propanamide

C14H14ClN3O2 (291.0774)


   

6-Bromoharminium(1+)

6-Bromoharminium(1+)

C13H12BrN2O+ (291.0133)


   

2-bromo-N-[2-(2-naphthalenyl)ethyl]acetamide

2-bromo-N-[2-(2-naphthalenyl)ethyl]acetamide

C14H14BrNO (291.0259)


   

parathion

parathion

C10H14NO5PS (291.033)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals

   

brimonidine

brimonidine

C11H10BrN5 (291.012)


S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics > S01GA - Sympathomimetics used as decongestants C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D - Dermatologicals Brimonidine (UK 14304) is a full α2-adrenergic receptor (α2-AR) agonist.

   

Acetamide, N-[4-[(2-pyridinylamino)sulfonyl]phenyl]-

Acetamide, N-[4-[(2-pyridinylamino)sulfonyl]phenyl]-

C13H13N3O3S (291.0678)


D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

   

Hawkinsin

Hawkinsin

C11H17NO6S (291.0777)


A cysteine derivative that is cysteine in which the thiol group is substituted by a [2-(carboxymethyl)-2,5-dihydroxycyclohex-3-en-1-yl]sulfanediyl group. Hawkinsinuria is an inherited disorder which is characterized by the inability to break down the amino acid tyrosine. This results in the finding of certain metabolites in the urine, such as hawkinsin.

   

Orciprenaline-3-O-sulfate

Orciprenaline-3-O-sulfate

C11H17NO6S (291.0777)


   

THS-044

THS-044

C11H12F3N3O3 (291.0831)


THS-044 binding stabilizes the HIF2α PAS-B folded state, for regulating HIF2 activity in endogenous and clinical settings. Target: HIF2α Limited trypsin proteolysis reveals that both apo and THS-044-bound protein are efficiently cut at R330 in the extended HI loop. In the THS-044 bound state, there appears no additional proteolysis at the remaining candidate trypsin sites. In contrast, these THS-044-protected sites are protease accessible in the unliganded protein, leading its complete degradation. In parallel, NMR-based deuterium exchange measurements revealed a dramatic stabilization of the THS-044-bound protein β-sheet, with some sites experiencing 100-fold enhanced protection factors relative to the ligand-free protein. THS-044 binding stabilizes the HIF2α PAS-B folded state, for regulating HIF2 activity in endogenous and clinical settings. Target: HIF2α Limited trypsin proteolysis reveals that both apo and THS-044-bound protein are efficiently cut at R330 in the extended HI loop. In the THS-044 bound state, there appears no additional proteolysis at the remaining candidate trypsin sites. In contrast, these THS-044-protected sites are protease accessible in the unliganded protein, leading its complete degradation. In parallel, NMR-based deuterium exchange measurements revealed a dramatic stabilization of the THS-044-bound protein β-sheet, with some sites experiencing 100-fold enhanced protection factors relative to the ligand-free protein.

   

16-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14,16,18-octaen-13-one

16-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14,16,18-octaen-13-one

C17H9NO4 (291.0532)


   

methyl 4-methoxy-5-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]furo[2,3-b]pyridine-6-carboxylate

methyl 4-methoxy-5-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]furo[2,3-b]pyridine-6-carboxylate

C14H13NO6 (291.0743)


   

(e)-n-({5-[(r)-methanesulfinyl]-4-methoxy-[2,2'-bipyridin]-6-yl}methylidene)hydroxylamine

(e)-n-({5-[(r)-methanesulfinyl]-4-methoxy-[2,2'-bipyridin]-6-yl}methylidene)hydroxylamine

C13H13N3O3S (291.0678)


   

methyl 4-methoxy-5-(3-methoxy-3-oxoprop-1-en-1-yl)furo[2,3-b]pyridine-6-carboxylate

methyl 4-methoxy-5-(3-methoxy-3-oxoprop-1-en-1-yl)furo[2,3-b]pyridine-6-carboxylate

C14H13NO6 (291.0743)


   

10-hydroxyliriodenine

NA

C17H9NO4 (291.0532)


{"Ingredient_id": "HBIN000147","Ingredient_name": "10-hydroxyliriodenine","Alias": "NA","Ingredient_formula": "C17H9NO4","Ingredient_Smile": "C1OC2=C(O1)C3=C4C(=C2)C=CN=C4C(=O)C5=C3C=C(C=C5)O","Ingredient_weight": "291.26 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35604","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11779019","DrugBank_id": "NA"}

   

6-bromo-2-(2-methylbut-3-en-2-yl)-1h-indole-3-carbaldehyde

6-bromo-2-(2-methylbut-3-en-2-yl)-1h-indole-3-carbaldehyde

C14H14BrNO (291.0259)


   

methyl 4-methoxy-5-[(1z)-3-methoxy-3-oxoprop-1-en-1-yl]furo[2,3-b]pyridine-6-carboxylate

methyl 4-methoxy-5-[(1z)-3-methoxy-3-oxoprop-1-en-1-yl]furo[2,3-b]pyridine-6-carboxylate

C14H13NO6 (291.0743)


   

2-hydroxy-4,7-dimethoxy-3-(2-methoxyethenyl)quinoline-5,8-dione

2-hydroxy-4,7-dimethoxy-3-(2-methoxyethenyl)quinoline-5,8-dione

C14H13NO6 (291.0743)


   

15-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14,16,18-octaen-13-one

15-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14,16,18-octaen-13-one

C17H9NO4 (291.0532)


   

(z)-n-({5-methanesulfinyl-4-methoxy-[2,2'-bipyridin]-6-yl}methylidene)hydroxylamine

(z)-n-({5-methanesulfinyl-4-methoxy-[2,2'-bipyridin]-6-yl}methylidene)hydroxylamine

C13H13N3O3S (291.0678)


   

(e)-n-({5-[(s)-methanesulfinyl]-4-methoxy-[2,2'-bipyridin]-6-yl}methylidene)hydroxylamine

(e)-n-({5-[(s)-methanesulfinyl]-4-methoxy-[2,2'-bipyridin]-6-yl}methylidene)hydroxylamine

C13H13N3O3S (291.0678)


   

18-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14,16,18-octaen-13-one

18-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14,16,18-octaen-13-one

C17H9NO4 (291.0532)


   

4-(2-aminoethyl)-6,7-dimethoxy-1,2,3-benzotrithiol-1-ium-1-olate

4-(2-aminoethyl)-6,7-dimethoxy-1,2,3-benzotrithiol-1-ium-1-olate

C10H13NO3S3 (291.0058)


   

(2r,3r,4s,4ar)-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-2,3,4,6-tetrol

(2r,3r,4s,4ar)-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-2,3,4,6-tetrol

C14H13NO6 (291.0743)


   

2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-2,3,4,6-tetrol

2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-2,3,4,6-tetrol

C14H13NO6 (291.0743)


   

2-hydroxy-n-[(1r,2s,6r)-2-hydroxy-6-(hydroxymethyl)-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzenecarboximidic acid

2-hydroxy-n-[(1r,2s,6r)-2-hydroxy-6-(hydroxymethyl)-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzenecarboximidic acid

C14H13NO6 (291.0743)


   

17-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14,16,18-octaen-13-one

17-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14,16,18-octaen-13-one

C17H9NO4 (291.0532)


   

9,11-diamino-10-chloro-2-methyl-3-oxo-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),4,6,8,10-pentaene-6-carboxamide

9,11-diamino-10-chloro-2-methyl-3-oxo-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),4,6,8,10-pentaene-6-carboxamide

C12H10ClN5O2 (291.0523)


   

n-({5-methanesulfinyl-4-methoxy-[2,2'-bipyridin]-6-yl}methylidene)hydroxylamine

n-({5-methanesulfinyl-4-methoxy-[2,2'-bipyridin]-6-yl}methylidene)hydroxylamine

C13H13N3O3S (291.0678)


   

7-(2-aminoethyl)-4,5-dimethoxy-1,2,3-benzotrithiol-1-ium-1-olate

7-(2-aminoethyl)-4,5-dimethoxy-1,2,3-benzotrithiol-1-ium-1-olate

C10H13NO3S3 (291.0058)


   

2-hydroxy-n-[2-hydroxy-6-(hydroxymethyl)-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzenecarboximidic acid

2-hydroxy-n-[2-hydroxy-6-(hydroxymethyl)-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzenecarboximidic acid

C14H13NO6 (291.0743)


   

2-hydroxy-4,7-dimethoxy-3-[(1e)-2-methoxyethenyl]quinoline-5,8-dione

2-hydroxy-4,7-dimethoxy-3-[(1e)-2-methoxyethenyl]quinoline-5,8-dione

C14H13NO6 (291.0743)